Intrinsic Value of S&P & Nasdaq Contact Us

Oncolytics Biotech Inc. ONCY NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

SharesGrow Score
36/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ONCY

Oncolytics Biotech Inc. (ONCY) has a market capitalization of $102.37M and trades at $1.02. The 52-week range is 0.33-1.51.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.4, Earnings Per Share (EPS) of $-0.30.

The stock has a beta of 0.88, operates in the Healthcare sector.

Trading Data
Current Price$1.02
52-Week Range0.33-1.51
Volume768.36K
Avg Volume (30D)1.42M
Market Cap$102.37M
Beta (1Y)0.88
Company
IPO Date2001-10-05
Employees28
CEOJared Kelly
CountryCA
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCA6823108759
CUSIP682310875
Income (Latest Year)
EBITDA$-28.73M
Operating Income$-28.73M
Net Income$-28.76M
EPS$-0.30
EPS Diluted$-0.30
Shares Outstanding$95.86M
Balance Sheet (Latest Year)
Total Assets$7.58M
Current Assets$6.84M
Cash & ST Investments$5.2M
Total Liabilities$11.38M
Total Debt$563K
Net Debt$-4.64M
Total Equity$-3.8M
Debt / Equity-0.15
Valuation Ratios
P/E Ratio-3.4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message